Verbali del cts: tutte le bufale che le istituzioni hanno raccontato e le verità che hanno nascosto su guanti, mascherine, sieri ed effetti avversi. Dai verbali del cts (il comitato tecnico scientifico) emergono una serie di bufale che hanno raccontato e di verità che hanno tenuto nascoste al pubblico. Proseguiamo su “Camelot – una tavola rotonda per la Verità” la lettura e l’analisi dei documenti interni all’organo consultivo del ministero della Salute con l’avvocato Roberto De Petro. https://www.radioroma.tv/2024/07/16/verbali-del-cts-tutte-le-bufale/

🛑 🛑 ESPLOSIVO: "I verbali del CTS (comitato tecnico-scientifico) certificano la presenza di un rappresentante della NATO alla riunione del 5 marzo del 2020" 👉 Un contributo fondamentale di PressKit che ricostruisce la vicenda a partire dalla denuncia dell’avv. Oddo e dai verbali desecretati. L’anello mancante per comprendere il legame fra le Istituzioni nazionali ed il coordinamento della NATO nella gestione “Corona”, dalle prime misure alla campagna pseudo-vaccinale. “Dopo le prime battute, in cui l’onorevole Ministro Speranza, parlando con i membri del comitato, afferma che alcune loro dichiarazioni nei giorni precedenti hanno creato disorientamento, viene introdotto il Generale Bonfiglio [...] appartenente al Punto Nato UEO del DPC [...] Ma che cos’è l’UEO? L’UEO è l’Unione dell’Europa Occidentale, un organo della NATO che, per quello che risulta, non dovrebbe più esistere dal 2011.” “il Generale Bonfiglio ricorda gli impegni relativi alla trattazione di documentazione riservata, sottolineando che la trasmissione dei documenti prodotti dal CTS avverrà d’ora in avanti tramite il Punto Nato UEO del DPC (Protezione Civile, ndr) e il Ministero della Salute.” “Questo è molto interessante per capire la portata di ciò che stiamo analizzando. In un verbale riguardante ricercatori, studiosi e scienziati che si occupano della salute pubblica, improvvisamente interviene un rappresentante della NATO, il Generale Bonfiglio, che a quanto pare non è rintracciabile online. Interviene e si frappone tra il CTS e i suoi componenti, dichiarando che da quel momento in poi tutto sarebbe passato attraverso la NATO.” “Nello stesso giorno, il 5 marzo 2020, al Pentagono si tiene una conferenza stampa, in cui alti esponenti del Dipartimento della Difesa americano discutono dello sviluppo di un vaccino contro il coronavirus.” Un tassello importante per capire e legare fra loro alcuni degli avvenimenti più importanti e drammatici della storia recente del nostro Paese, e non solo. Qui l’articolo 👉 https://presskit.it/2024/09/27/verbali-del-cts-certificano-la-presenza-un-rappresentate-della-nato-alla-riunione-del-5-marzo-del-2020-avv-andrea-oddo-lo-giorno-pentagono-parla-vaccini-quindi-non-lo-diceva-la-sc/ Qui i verbali desecretati 👉 https://github.com/pcm-dpc/COVID-19-Verbali-CTS/blob/master/elenco-verbali.md Fonte: https://t.me/canalemiracolomilano

COME IN 1984: RISCRIVONO LA STORIA E LE LEGGI PAZZESCO, SU WIKIPEDIA AVEVANO CAMBIATO LA TRADUZIONE DEL CODICE DI NORIMBERGA CHE POI SI E' DIFFUSA FALSIFICATA. PENSAVANO DI GIUSTIFICARE LE IMPOSIZIONI VACCINALI E FARCI FESSI. Ho già messo la traduzione corretta. Questo il testo originale in inglese dell'art. 1 prima parte da due fonti qui sotto -BRITISH MEDICAL JOURNAL No 7070 Volume 313: Page 1448, 7 December 1996. -The University of North Carolina  “Permissible Medical Experiments.” Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Nuremberg October 1946 – April 1949, WASHINGTON. U.S. GOVERNMENT PRINTING OFFICE (N.D.), VOL. 2., PP. 181-182. art.1) The voluntary consent of the human subject is absolutely essential. This means that the person involved should have legal capacity to give consent; should be situated as to be able to exercise free power of choice, without the intervention of any element of force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or coercion, and should have sufficient knowledge and comprehension of the elements of the subject matter involved as to enable him to make an understanding and enlightened decision. … Ma su Enciclopedia Britannica hanno già semplificato Art.1) Voluntary consent of the human subject in the experimentation is absolutely essential. E IL RESTO?? Questa la traduzione su Wikipedia che poi è finita in altri siti. 1. Il consenso volontario è assolutamente essenziale. Ciò significa che la persona interessata deve avere capacità giuridica di esprimere il consenso; deve essere in grado di esercitare il libero potere decisionale senza che si intervenga con la forza, con la frode, con l'inganno, con minacce o con qualsiasi forma sproporzionata di vincolo o coercizione; deve avere sufficiente conoscenza e comprensione degli elementi implicati nello studio, tali da consentire una decisione consapevole e ragionata. ... SPROPORZIONATA non esiste IN INGLESE, qualcuno voleva giustificare le imposizioni Questa è la traduzione automatica Google. 1. Il consenso volontario del soggetto umano è assolutamente essenziale. Ciò significa che la persona coinvolta deve avere la capacità giuridica di dare il consenso; deve essere in una situazione tale da poter esercitare il libero potere di scelta, senza l'intervento di alcun elemento di forza, frode, inganno, coercizione, abuso o altra ulteriore forma di costrizione o coercizione; e deve avere sufficiente conoscenza e comprensione degli elementi dell'oggetto in questione da consentirle di prendere una decisione comprensiva e illuminata.... Se dovessi difendermi in tribunale però citerei solo questa: CONVENZIONE SUI DIRITTI DELL'UOMO E LA BIOMEDICINA. Convenzione per la protezione dei Diritti dell’Uomo e della dignità dell’essere umano nei confronti dell’applicazioni della biologia e della medicina : Oviedo, 4 aprile 1997 adottata a Nizza il 07.12.00 e ratificata dallo Stato italiano con legge 28.03.01, n. 145. COUNCIL OF EUROPE mettiamo il English Official Texts e poi la traduzione Chapter I – Article 2 – Primacy of the human being The interests and welfare of the human being shall prevail over the sole interest of society or science. Articolo 2 – Primato dell’essere umano L’interesse e il bene dell’essere umano debbono prevalere sul solo interesse della società o della scienza. Chapter II – Consent Article 5 – General rule. An intervention in the health field may only be carried out after the person concerned has given free and informed consent to it. This person shall beforehand be given appropriate information as to the purpose and nature of the intervention as well as on its consequences and risks. The person concerned may freely withdraw consent at any time. Capitolo II – Consenso Articolo 5 – Regola generale. Un intervento nel campo della salute può essere effettuato solo dopo che la persona interessata vi abbia dato il proprio consenso libero e informato. Questa persona riceve innanzitutto una informazione adeguata sullo scopo e sulla natura dell’intervento e sulle sue conseguenze e i suoi rischi. La persona interessata può, in qualsiasi momento, liberamente ritirare il proprio consenso. NON LEGGERE SOLO LE NOTIZIE. ISCRIVITI E PUBBLICA SU SCENARIO.PRESS ADERISCI AD INSIEMELIBERI.ORG CONFEDERAZIONE POLITICA NAZIONALE.

La capacità di sintesi e divulgazione del Prof. Roy de Vita é come sempre immensa. Grazie🙏 LABORATORIO PER BAMBINI TRANS-GENDER UNIVERSITÀ ROMA 3. APPROVATO dal COMITATO ETICO SCIENTIFICO DELL'UNIVERSITÀ. MASSIMA CONDIVISIONE. GRAZIE. Fonte: https://x.com/itsmeback_/status/1839196141830758704?t=IhgCXj042J4Qs872R71qow&s=19

Fill-finish Pharmaceutical Contract Market Global outlook 2024 to 2031 | Skyquest Leading market research firm SkyQuest Technology Group recently released a study titled 'Fill-finish Pharmaceutical Contract Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Fill-finish Pharmaceutical Contract report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Fill-finish Pharmaceutical Contract Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Fill-finish Pharmaceutical Contract Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Fill-finish Pharmaceutical Contract Market circumstances in the forecast period between 2024 and 2031. The global Fill-finish Pharmaceutical Contract Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Fill-finish Pharmaceutical Contract Market has experienced robust growth over the past decade and is projected to continue expanding. In 2022, the global fill-finish pharmaceutical contract manufacturing market reached a significant value of USD 8.1 billion. Projections indicate that this market is poised for steady growth, with an estimated compound annual growth rate (CAGR) of 6.1% expected from 2024 to 2031. This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/fill-finish-pharmaceutical-contract-manufacturing-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Fill-finish Pharmaceutical Contract Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. By Product Type - Prefilled Syringes, Vials, Cartridges, Others By Molecule Type - Large Molecules, Small Molecules By End-user - Biopharmaceutical Companies, Pharmaceutical Companies By Region - North America, Asia Pacific, Latin America, Europe Get your customized report @ https://www.skyquestt.com/speak-with-analyst/fill-finish-pharmaceutical-contract-manufacturing-market Following are the players analyzed in the report: AbbVie Inc. Boehringer Ingelheim Pfizer Catalent Inc Recro Pharma, Inc. Baxter’s BioPharma Solutions Eurofins Scientific Symbiosis Pharmaceutical Service MabPlex International Co. Ltd. Recipharm AB Fresenius Kabi Contract Manufacturing Novartis Regional Analysis 1. North America: - The United States and Canada dominate the North American Fill-finish Pharmaceutical Contract Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Fill-finish Pharmaceutical Contract consumption. 2. Europe: - Europe is a significant player, with major Fill-finish Pharmaceutical Contract Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Fill-finish Pharmaceutical Contract manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Fill-finish Pharmaceutical Contract Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Fill-finish Pharmaceutical Contract Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/fill-finish-pharmaceutical-contract-manufacturing-market

"The perfect soldier" Sinossi In quella zona grigia in cui i confini tra difesa e attacco si confondono, prospera la ricerca scientifica più finanziata al mondo: quella militare. Il suo scopo principale è sempre stato quello di creare l’arma perfetta, il soldato perfetto. Oggi con gli strumenti tecnologici a disposizione potrebbe riuscirci. Attraverso il pipistrello, l’animale sacro dell’Oriente che ospita virus che possono essere ingegnerizzati, ma che é anche l’unico mammifero con una speciale proteina che lo rende immune ai virus e al cancro, ci addentriamo fra i progetti nascosti del Dipartimento della Difesa statunitense. Prodotto da OVALRome Trailer Organizza una proiezione di The Perfect Soldier Nella tua città Lasciaci un tuo recapito, senza alcun impegno. Ti contatteremo e ti daremo tutte le informazioni e il supporto di cui hai bisogno. Grazie! Calendario Le proiezioni di The Perfect Soldier 15/09/24 Uboldo (VA) Ore 20:00 – Centro Sportivo, via Manzoni 251 Evento gratuito Per info e prenotazioni: WhatsApp 3452307369 24/09/24 Trento Ore 20:00 – Sala Auditorium, via Giusti 35 Evento gratuito – Prenotazione obbligatoria In collegamento Nathalie Signorini Per info e prenotazioni: dsptrentino@gmail.com 26/09/24 Milano Ore 21:00 – Teatro San Lorenzo alle Colonne Evento gratuito – Prenotazione obbligatoria Con Maria Rita Gismondo, Massimo Cacciari e Nathalie Signorini Per info e prenotazioni: jtmv812@gmail.com

Oncology Market Rising Trends, Demand and Future Scope 2024 to 2031 Leading market research firm SkyQuest Technology Group recently released a study titled 'Oncology Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Oncology report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Oncology Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Oncology Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Oncology Market circumstances in the forecast period between 2024 and 2031. The global Oncology Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Oncology Market has experienced robust growth over the past decade and is projected to continue expanding. Oncology Market size was valued at USD 286.04 billion in 2022 and is poised to grow from USD 309.3 billion in 2023 to USD 581.25 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/oncology-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Oncology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. Cancer Diagnostics & Treatment Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy} Cancer Type Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer End-Use Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics Get your customized report @ https://www.skyquestt.com/speak-with-analyst/oncology-market Following are the players analyzed in the report: Roche Holding AG Novartis International AG Bristol-Myers Squibb Company Pfizer Inc. Merck & Co., Inc. AstraZeneca PLC Johnson & Johnson Sanofi S.A. Takeda Pharmaceutical Company Limited Amgen Inc. AbbVie Inc. Eli Lilly and Company Gilead Sciences, Inc. Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company) Bayer AG Biogen Inc. Daiichi Sankyo Company, Limited Astellas Pharma Inc. Eisai Co., Ltd. Teva Pharmaceutical Industries Ltd. Regional Analysis 1. North America: - The United States and Canada dominate the North American Oncology Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Oncology consumption. 2. Europe: - Europe is a significant player, with major Oncology Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Oncology manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Oncology Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Oncology Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/oncology-market

SE AVEVATE QUALCHE DUBBIO ECCO DA CHE PARTE STA L'ONU! Il segretario generale dell’Onu Guterres chiede la censura. “Le piattaforme digitali vengono utilizzate in modo improprio per indebolire la scienza e diffondere disinformazione e odio a miliardi di persone”. Ha chiesto il coordinamento contro questa minaccia.. IF YOU HAD ANY DOUBTS, HERE'S WHERE THE UN IS ON! UN Secretary General Guterres calls for censorship. "Digital platforms are being misused to undermine science and spread misinformation and hate to billions of people." He called for coordination against this threat.

Drug Screening Market: Competitive Insights and Precise Outlook | 2024-2031 Drug Screening Market Overview: A lot of factors, such as geographic growth, segmentation, and market size by value and volume, are taken into account in the SkyQuest Technology Group research to provide a full and accurate analysis of the global Drug Screening market. This outstanding research study was created specifically to provide the most latest data on significant aspects of the global Drug Screening Industry. Numerous market estimates are provided in the analysis, including those for market size, output, revenue, consumption, CAGR, gross margin, price, and other critical factors. The best primary and secondary research methods and tools on the Drug Screening market were used to build it. Numerous research studies are included in it, including ones on pricing analysis, production and consumption analysis, company profile, and manufacturing cost analysis. Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031). The competitive environment is a crucial element that every key factor needs to be aware of. The study explains the market's competitive landscape so that readers may gauge the degree of both domestic and global rivalry. Additionally, market researchers have provided summaries of each significant firm in the global Drug Screening industry, taking into consideration crucial elements including operational areas, production, and product portfolio. When analyzing the organizations in the study, significant factors including business size, market share, market growth, revenue, production volume, and profitability are also taken into account. The study report uses both qualitative and quantitative data to offer a thorough view of the market. It examines and forecasts the global market in a number of critical industries. The research provides a thorough overview of the industry by segmenting the Drug Screening market into groups based on application, end-user, and location. A thorough research of each market segment was conducted, taking into consideration current and upcoming market trends. Chance to get a free sample @ https://www.skyquestt.com/sample-request/drug-screening-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Drug Screening Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. • Product & Service o Drug Screening Services [Laboratory Testing Services, On-site Testing Services], Drug Screening Products [Analytical Instruments (By Type {Breathalyzers “Fuel-cell Breathalyzers, Semiconductor Breathalyzers, Other Breathalyzers”, Immunoassay analyzers, Chromatography instruments}, By Modality {Hand-held drug screening products, Benchtop drug screening products}, Rapid Testing Devices (Urine testing devices {Drug testing cups, Dip cards, Drug testing cassettes}, Oral fluid testing devices), Consumables {Assay kit, Sample collection devices, Calibrators and controls, Other consumables}] • Sample Type o Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples • Drug Type o Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, Other Drugs • End User o Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, Other End Users Get your Customized report @ https://www.skyquestt.com/speak-with-analyst/drug-screening-market Following are the players analyzed in the report: • Quest Diagnostics (US) • Abbott (US) • OraSure Technologies Inc. (US) • Alfa Scientific Designs Inc. (US) • Thermo Fisher Scientific, Inc. (US) • Drägerwerk AG & Co. KGaA (Germany) • Lifeloc Technologies, Inc. (US) • MPD Inc. (US) • Omega Laboratories, Inc. (US) • Premier Biotech, Inc. (US) • Psychemedics Corporation (US) • F. Hoffmann-La Roche Ltd. (Switzerland) • Shimadzu Corporation (Japan) • Siemens Healthineers AG (Germany) • American Bio Medica Corporation (US) • ACM Global Laboratories (US) • CareHealth America Corp. (US) • Clinical Reference Laboratory, Inc. (US) • Intoximeters (US) • Sciteck, Inc. (US) • AccuSourceHR, Inc. (US) • Cordant Health Solutions (US) • Intoxalock (US) • Millennium Health (US) • AdvaCare Pharma (US) Motives for purchasing this report- - A full understanding of customer experiences, upcoming trends, and growth drivers may be obtained by market category analysis. -Drug Screening Market participants will be able to quickly decide on their course of action in order to achieve a competitive advantage thanks to the essential information provided in this area. The factors affecting the sales prospect are carefully examined by SkyQuest Technology Group across several important categories. - Analysing market categories can provide detailed insights into consumer experiences, upcoming trends, and growth-promoting factors. A thorough analysis of market manufacturing trends is a crucial component of the study. -These observations offer crucial information on the ways in which market participants are reacting to the most recent developments that are oversaturating the market. -An in-depth analysis of the numerous organic Buy your full Market Report now: https://www.skyquestt.com/buy-now/drug-screening-market FAQs: 1. What are the main vendors' points of strength and weakness? 2. What are the primary business plans of the leading important players for the near future? 3. What will the market size and growth rate be for Drug Screening in the upcoming year? 4. Which prevailing global trends are affecting the Drug Screening market shares of the leading regions? What effect does Covid19 have on the Industry right now?

Convegno: "Le nuove frontiere della Medicina fra scienza e mistica" - un percorso esplorativo per esplorare l'opportunità di nuove forme terapeutiche che fondono insieme antiche e nuove conoscenze. Scopo del convegno è sollecitare riflessioni che portino allo sviluppo di strumenti di cura più efficaci e, soprattutto più umani. Erminia Ferrari e Fondazione NOVACANA presentano: "Le nuove frontiere della medicina tra scienza e mistica" - parte nona - Seriate (BG) - 14 Settembre 2024 Intervento di Federico Faggin - Fisico, Inventore ed Imprenditore - 3 parte https://rumble.com/v5fjfzf-le-nuove-frontiere-della-medicina-tra-scienza-e-mistica-6-parte-f.-faggin.html?mref=2wyiuy&mc=6s5ce #federicofaggin #faggin #lenuovefrontieredellamedicina